IC

Ikarian Capital Portfolio holdings

AUM $302M
This Quarter Return
+2.37%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
AUM
$360M
AUM Growth
+$360M
Cap. Flow
+$8.2M
Cap. Flow %
2.28%
Top 10 Hldgs %
35.72%
Holding
175
New
41
Increased
20
Reduced
27
Closed
26

Sector Composition

1 Healthcare 96.72%
2 Industrials 0%
3 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
TNGX icon
101
Tango Therapeutics
TNGX
$723M
$2K ﹤0.01%
+250
New +$2K
CCXI
102
DELISTED
ChemoCentryx, Inc.
CCXI
$1K ﹤0.01%
+37
New +$1K
ADVM icon
103
Adverum Biotechnologies
ADVM
$66.9M
-22,840
Closed -$477K
AL icon
104
Air Lease Corp
AL
$7.13B
0
ALNY icon
105
Alnylam Pharmaceuticals
ALNY
$59B
0
ARGX icon
106
argenx
ARGX
$43.6B
-1,750
Closed -$394K
ARVN icon
107
Arvinas
ARVN
$575M
0
ARWR icon
108
Arrowhead Research
ARWR
$3.7B
0
ASND icon
109
Ascendis Pharma
ASND
$12.2B
0
AUPH icon
110
Aurinia Pharmaceuticals
AUPH
$1.54B
-327,771
Closed -$5.33M
AXSM icon
111
Axsome Therapeutics
AXSM
$6.09B
0
BBIO icon
112
BridgeBio Pharma
BBIO
$9.92B
0
BCLI
113
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
0
BMRN icon
114
BioMarin Pharmaceuticals
BMRN
$11.3B
0
BPMC
115
DELISTED
Blueprint Medicines
BPMC
-201,662
Closed -$15.7M
CLLS
116
Cellectis
CLLS
$262M
-73,067
Closed -$1.3M
CRBP icon
117
Corbus Pharmaceuticals
CRBP
$119M
0
CRSP icon
118
CRISPR Therapeutics
CRSP
$4.82B
0
CVM icon
119
CEL-SCI Corp
CVM
$80.8M
0
CYRX icon
120
CryoPort
CYRX
$430M
0
DNTH icon
121
Dianthus Therapeutics
DNTH
$793M
-8,674
Closed -$65K
FATE icon
122
Fate Therapeutics
FATE
$116M
0
FGEN icon
123
FibroGen
FGEN
$48.1M
0
FXI icon
124
iShares China Large-Cap ETF
FXI
$6.65B
0
GILD icon
125
Gilead Sciences
GILD
$140B
-6,218
Closed -$478K